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Introduction: a survey on peri-operative nutritional support in pancreatic and biliary surgery among Spanish hospitals in 2007 showed that few 
surgical groups followed the 2006 ESPEN guidelines. Ten years later we sent a questionnaire to check the current situation.
Methods: a questionnaire with 21 items sent to 38 centers, related to fasting time before and after surgery, nutritional screening use and type, 
time and type of peri-operative nutritional support, and number of procedures.
Results: thirty-four institutions responded. The median number of pancreatic resections (head/total) was 29.5 (95 % CI: 23.0-35; range, 5-68) 
(total, 1002); of surgeries for biliary malignancies (non-pancreatic), 9.8 (95 % CI: 7.3-12.4; range, 2-30); and of main biliary resections for benign 
conditions, 10.4 (95 % CI: 7.6-13.3; range, 2-33). Before surgery, only 41.2 % of the sites used nutritional support (< 50 % used any nutritional 
screening procedure). The mean duration of preoperative fasting for solid foods was 9.3 h (range, 6-24 h); it was 6.6 h for liquids (range, 2-12). 
Following pancreatic surgery, 29.4 % tried to use early oral feeding, but 88.2 % of the surveyed teams used some nutritional support; 26.5 % 
of respondents used TPN in 100 % of cases. Different percentages of TPN and EN were used in the other centers. In malignant biliary surgery, 
22.6 % used TPN always, and EN in 19.3 % of cases.
Conclusions: TPN is the commonest nutrition approach after pancreatic head surgery. Only 29.4 % of the units used early oral feeding, and 
32.3 % used EN; 22.6 % used TPN regularly after surgery for malignant biliary tumours. The 2006 ESPEN guideline recommendations are not 
regularly followed 12 years after their publication in our country. 
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INTRODUCTION
The issue of nutrition around pancreatic and biliary surgery has 
not been solved yet (1-3). Complex procedures with a high rate 
of complications make it difficult to standardize the nutritional 
support needed. Though mortality is less than 5 % in specialist 
centers, morbidity is around or exceeding 50 % (4-6). Malnutrition 
before surgery and as the effect of surgical complications makes 
the nutritional management of these patients an unavoidable task.
We performed a nationwide survey in Spain in 2007 about pe-
rioperative nutritional management in pancreatobiliary surgery. We 
contacted 33 surgical units and received responses from 25 (75.7 %) 
of them. The survey was based on 18 simple questions related to 
perioperative nutritional care habits. The results were published in 
the journal Nutrición Hospitalaria (7). We realized that the situation 
in Spain at that time was far from the recommendations issued by 
ESPEN (8). Parenteral nutrition was the most prevalent modality of 
support (82.6 %), and enteral nutrition (via a nasojejunal tube or je-
junostomy) was used only in 21.7 % of Units in pancreatic surgery. 
Ten years later, we decided to send a similar questionnaire to 
assess the current situation in Spain. 
MATERIALS AND METHODS
A questionnaire with 21 items was sent to 38 centers with 
known activity in pancreatic and biliary surgery. Questions were 
related to fasting time (hours) before and after surgery (liquid and 
solid), nutritional screening use and type, time (days) and type of 
peri-operative nutritional support (enteral by tube or jejunostomy, 
parenteral) and number of procedures of each type (pancreatic 
and biliary, benign and malignant). The results obtained from the 
different centers were transferred to an Excel sheet and analyzed.
STATISTICAL ANALYSIS
In the descriptive analysis, categorical variables are presented 
with their frequency distribution (numbers and percentages) and 
quantitative variables as mean and median values with confidence 
interval (CI) and range.
RESULTS
We received responses from 34 institutions (89.5 %). The me-
dian number of pancreatic resections (head and/or total pancrea-
tectomies) was 29.5 (95 % CI: 23.0-35; range, 5-68) (totalling 
1,002 cases). Surgery for biliary malignancies (non-pancreatic, 
above the pancreatic gland) averaged 9.8 (95 % CI: 7.3-12.4; 
range, 2-30), and the mean number of main biliary resections for 
benign conditions, non related to liver transplantation reconstruc-
tion of the biliary tree, was 10.4 (95 % CI: 7.6-13.3; range, 2-33) 
(Fig. 1, number of procedures).
Before surgery only 41.2 % of the groups used nutritional su-
pport and less than 50 % used any nutritional screening method. 
The mean duration of preoperative solid food fasting was 9.3 h 
(range, 6-24 h). It was 6 hours in 11 centers and 8 hours in 12. 
Mean preoperative fasting was 6.6 h for liquids (range, 2-12), it 
being 2 hours in only 5 centers and 4 hours in one. It was 6 or 
8 hours in the majority of Units (Fig. 2).
Following pancreatic surgery, 29.4 % of respondents tried to use 
early oral feeding, but 88.2 % of the groups involved used some nu-
tritional support. In 26.5 % of the groups TPN was used for 100 % 
of cases. It was used for 0-20 % of cases in 50 % of the responding 
centres (Fig. 3). The mean number of PN days was 6. Different 
percentages of TPN and EN were used in the other centers. Sixteen 
centers did not use EN or PN in only 0-10 % of their cases. 
Jejunostomy was used only in 3 centers (in 20-30 % of the 
patients). Tube EN use was highly variable – 26 centers did not 
use it, but 12 were using it in 1-90 % of their cases. EN was used 
for a mean of 3.7 days (median, 5 days).
Postoperative oral feeding was initiated at a median of 2 days 
(mean, 2.5 days) after pancreatectomy. One center started it on 
post-operative day (POD) 0, 9 in POD 1, 9 in POD 2, and 15 in 
POD 3-5. There was great variability for solids; in 1 center they 
started them on POD1, in 3 on POD 2, in 9 on POD 3, and in 1 





Introducción: realizamos una encuesta sobre soporte nutricional perioperatorio en cirugía pancreática y biliar en hospitales españoles en 2007, 
que mostró que pocos grupos quirúrgicos seguían las guías de ESPEN 2006. Diez años después enviamos un cuestionario para comprobar la 
situación actual.
Métodos: treinta y ocho centros recibieron un cuestionario con 21 preguntas sobre tiempo de ayunas antes y después de la cirugía, cribado 
nutricional, duración y tipo de soporte nutricional perioperatorio, y número de procedimientos.
Resultados: respondieron 34 grupos. La mediana de pancreatectomías (cabeza/total) fue de 29,5 (IC 95 %: 23,0-35; rango, 5-68) (total, 1002), 
la de cirugías biliares malignas de 9,8 (IC 95 %: 7,3-12,4; rango, 2-30) y la de resecciones biliares por patología benigna de 10,4 (IC 95 %: 
7,6-13,3; rango, 2-33). Solo el 41,2 % de los grupos utilizaban soporte nutricional antes de la cirugía (< 50 % habian efectuado un cribado 
nutricional). El tiempo medio de ayuno preoperatorio para sólidos fue de 9,3 h (rango, 6-24 h), y de 6,6 h para líquidos (rango, 2-12). Tras la 
pancreatectomía, el 29,4 % habían intentado administrar una dieta oral precoz, pero el 88,2 % de los grupos usaron algún tipo de soporte 
nutricional y el 26,5 % usaron NP en el 100 % de los casos. Los demás grupos usaron diferentes porcentajes de NP y NE en sus casos. En la 
cirugía biliar maligna, el 22,6 % utilizaron NP siempre y NE en el 19,3 % de los casos.
Conclusiones: la NP es el soporte nutricional más utilizado tras la cirugía de cabeza pancreática. Solo el 29,4 % de las unidades usan nutrición 
oral precoz y el 32,3 % emplean la NE tras este tipo de cirugía. El 22,6 % de las instituciones usan NP habitualmente tras la cirugía de tumores 
biliares malignos. Las guías ESPEN 2006 no se siguen de forma habitual en nuestro país tras más de 10 años desde su publicación.
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Figure 3.
Percentage distribution of parenteral nutrition use in patients after pancreatectomy 
at the different study centers.
Figure 1.
Number of procedures of each type – total, mean by center, and range.
Figure 2.
Distribution of fasting time for solid and liquid diet in the units that responded to 
the survey. 
In malignant biliary surgery, 22.6 % of centers used TPN 
always, and 6 additional centers in 40-80 %. EN was used in 
19.3 % of centers. Five centers used EN in 10-80 % of cases, 
and 7 centers used neither EN nor PN. 
The use of artificial nutrition in benign biliary surgery was much 
less frequent. Almost 80 % of the responding Units used EN or 
PN in < 20 % of their cases. Only 3 centers used PN in 50 % of 
their cases.
DISCUSSION
Concerned by the low adherence of Spanish centers to the 
2006 ESPEN guidelines on enteral nutrition after pancreatic sur-
gery in 2007, we decided to review this issue a decade later. En-
teral nutrition guidelines remained unchanged (8), and parenteral 
nutrition guidelines after surgery were published shortly after our 
first survey was carried out (9). The ESPEN guidelines on clinical 
nutrition in surgery published in 2017 (10) are an update of those 
two and the the German Society for Nutritional Medicine (DGEM) 
Guideline “Clinical Nutrition in Surgery” of 2013, but they contain 
no substantial differences with respect to the previous guidelines 
in relation to nutrition in upper gastrointestinal or pancreatic sur-
gery. They appeared at the same time we had our survey readied, 
similar to what happened in 2006. We sent our questionnaire to 
38 centers with known activity in pancreatic surgery, and obtained 
a high response rate (89.5 %).
  Pancreatectomies 1002
•  Mean 29.5 (5-68)
  Non-pancreatic biliary malignancies surgery 305
•  Mean 5.8 (2-30)
  Hepaticojejunostomies 344
•  Mean 10.4 (2-33)
2
6 8 10 12 24
4 6 8 12
Preoperative solid diet fasting
Preoperative liquid fasting
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As centers were of different sizes, there was great variability in 
the number of procedures performed, ranging from 5 to 68 pan-
createctomies (head or total-gland resections) in a year (2017), 
but with a significant median of 29.5 surgeries. Surgery for ma-
lignant biliary tree tumors involved fewer patients as expected, 
with numbers ranging from 2 to 30. Finally, procedures for be-
nign biliary problems, i.e., biliary-enteric anastomoses in the liver 
transplantation setting, involved a median of 10 cases/center/year. 
Malnutrition and/or significant weight loss in pancreatic and 
biliary cancer patients is not unusual (27-74 %) (11-12). All these 
patients should be nutritionally evaluated (3), but there are still 
many centers that do not use nutritional screening routinely. In 
our recent survey, less than 50 % of Units used any nutritional 
screening tool. Accordingly, only 41.2 % of the responding groups 
were using nutritional support before surgery. 
The Espen Guidelines on Enteral Nutrition from 2006 (8) indi-
cated EN even in patients without obvious undernutrition when it 
is anticipated that the patient will be unable to eat for more than 
7 days perioperatively, and also in patients who cannot main-
tain their oral intake above 60 % of the recommended intake for 
more than 10 days. A delay in surgery to allow preoperative EN 
was recommended for patients at severe nutritional risk, defined 
by the presence of at least one of the following criteria: weight 
loss > 10-15 % within 6 months, BMI < 18.5 kg/m2, Subjective 
Global Assessment (SGA) Grade C, and serum albumin < 30 g/L 
(with no evidence of hepatic or renal dysfunction).
The ISGPS (International Study Group on Pancreatic Surgery) 
position paper (3) recommends nutritional support if one of the 
following criteria is met (almost the same parameters, but con-
sidering weight loss only if > 15 % and adding the nutritional 
risk score as an alternative to SGA): weight loss > 15 % within 
6 months, BMI < 18.5 kg/m2, SGA grade C or nutritional risk sco-
re > 5, and serum albumin < 30 g/L (with no evidence of hepatic 
or renal dysfunction).
As regards preoperative fasting, there was great variability in 
the durations reported by the responding Units. Anesthesia society 
guidelines support the current use of 2 hours fasting for liquids 
and 6 hours fasting for solids (13-14), as there is no evidence of 
a higher risk for aspiration when compared to traditional, longer- 
time schedules. We saw that some surgical teams followed these 
guidelines while others were still using much longer fasting times 
both for liquids and solids. The most recent ESPEN guidelines on 
clinical nutrition in surgery (10) state that preoperative fasting from 
midnight is unnecessary in most patients with the highest grade 
of recommendation, as this had reached a very strong consensus 
among the authors (97 %).
Postoperative early feeding is another issue that has changed 
tremendously in recent years. The ESPEN 2017 guidelines re-
commend oral intake within hours in most patients (10). Recent 
meta-analyses showed significant benefits in terms of postope-
rative recovery and infection rates (15). The guidelines dealing 
with perioperative care for pancreaticoduodenectomy, published 
by the ERAS Society (16), state that most patients tolerate nor-
mal oral intake soon after elective pancreaticoduodenectomy, and 
recommend allowing a normal diet after surgery without resctric-
tions albeit with caution, starting carefully and increasing intake 
according to tolerance over 3-4 days. Their reccomendation is 
to use enteral tube feeding only for specific indications, and that 
parenteral nutrition should not be employed routinely. Bozzetti and 
Mariani challenge this point of view (16) arguing that there is a high 
prevalence of malnutrition in patients with pancreatic cancer, and 
there is evidence that many of these patients should be candidates 
for perioperative nutritional support according to the ESPEN gui-
delines. There may be a gap between the recommended and the 
effective start of feeding, and though the ERAS guidelines discou-
rage the use of a nasogastric/jejunal tube or of a needle-catheter 
jejunostomy, their use could prove beneficial in patients who are 
recognized at high risk for postoperative complications. 
The 2006 ESPEN guidelines support the use of enteral supple-
mentation in those patients that are not able to cover at least 60 % 
of their energy requirements by the oral route. This can be done 
by tube or jejunostomy feeding, and each method has its pros 
and cons. Our survey showed that jejunostomy was used only in 
3 centers and in 20-30 % of patients, and that the use of tube 
EN was highly variable, only in one third of the responding centers 
and in very different percentages of patients. 
More worrying is the widespread use of parenteral nutrition. In 
more than one quarter of the groups TPN was used for 100 % of 
cases. It was used for 0-20 % of cases in 50 % of the responding 
centers, but in more than 80 % of patients in 10 centers. The 
2009 ESPEN guidelines (9) recommend its preoperative use in 
malnourished hospitalized patients who cannot be adequately fed 
either orally or enterally, and the use of postoperative parenteral 
nutrition in patients who cannot meet their caloric requirements 
within 7-10 days whether orally or enterally. Patients on parenteral 
nutrition need close monitoring to reduce the risk of thromboem-
bolic, infectious, and metabolic complications (17).
As for the use of TPN in malignant biliary surgery, the survey 
showed that more than 20 % of the groups assessed were using it 
always, and 6 more units used it in 40-80 % of their cases. These 
results show a liberal use of parenteral nutrition in this subgroup 
of patients as well, something that goes in parallel with the policy 
followed in pancreatic surgery. This could not be justified by the 
use of the current guidelines, unless a high proportion of the pa-
tients involved were undernourished before surgery, something 
unusual nowadays and imposible to demonstrate by the nature 
of a simple survey without laboratory and in-depth nutritional as-
sessment data. Conversely, the use of enteral nutrition was scarce 
(less than 20 % of the responding Units, though in 5 centers it 
was used for 10-80 % of cases). 
The results obtained about the use of artificial nutrition in the 
setting of benign biliary surgery are different, as expected. This 
surgery is usually simpler and less frequently followed by seve-
re complications, which explains that almost 80 % of the Units 
assessed used EN or PN in < 20 % of their cases. But still, 3 of 
the centers were using PN in 50 % of their cases, something 
that sounds out of the ordinary, and should be a reason for policy 
review.
Potential methodological inconsistencies of this work may be rela-
ted to the nature of the study. It being a survey that was sent to most 
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of the different Units that perform pancreatic and biliary surgery in 
Spain, without an audit made afterwards, makes it possible that some 
of the results received do not exactly represent the real experience of 
some of the working groups. However, personal co mmunications 
and interpersonal knowdlege support most of the results shown, in 
many cases unfortunately distant from current recommendations. 
This publication may also work as a stimulus for change.
CONCLUSIONS
TPN is the most usual nutritional support after pancreatic head 
surgery in Spain. Only 29.4 % of the assessed Units use early oral 
feeding, and 32.3 % use enteral feeding after this kind of surgery.
In all, 22.6 % of the surveyed institutions use TPN regularly 
after surgery for malignant biliary tumours. The 2006 (enteral) 
and 2009 (parenteral) ESPEN guideline recommendations are not 
regularly followed in our country a decade after their publication. 
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